// App-Quantinova.ai

Abstract 11792 : Low Penetrance Sarcomere Variants Indicate an Additive Genetic Risk Model in Hypertrophic Cardiomyopathy

Researchers

Presenter

  • Eric Smith

Principal Investigators

  • Gabriela Chen

  • Yao-chang Tsan

  • John Stendahl

  • Jodie Ingles

  • Victoria N Parikh

  • Samuel Wittekind

  • Steven Colan

  • Neal K Lakdawala

  • Anjali T Owens

  • Daniel L Jacoby

  • Sharlene Day

  • Christopher Semsarian

  • iacopo olivotto

  • Carolyn Ho

  • Mark W Russell

  • Sara Saberi

  • James S Ware

  • Adam S Helms

Medical Centers

  • HOSP OF THE UNIV OF PENNSLYVANIA, Wallingford, PA

  • Cincinnati Children's Hospital, Cincinnati, OH

  • VA, New Haven, CT

  • UNIVERSITY OF SYDNEY, Newtown, Australia

  • Yale University School of Medicine, New Haven, CT

  • UNIVERSITY OF MICHIGAN, Ann arbor, MI, USA

  • Imperial College London, London, NY

  • University of Pennsylvania, Philadelphia, PA

  • University of Michigan, Ann Arbor, MI

  • BRIGHAM AND WOMENS HOSPITAL, Boston, MA

  • Careggi Hospital, Florence, Italy

  • Boston Children's Hospital, Boston, MA

  • Sydney, Australia

  • Brigham & Women's Hospital, Boston, MA

  • Univ of Michigan, ANN ARBOR, MI

  • STANFORD UNIV SCH OF MED, Stanford, CA

Locations

  • United States

  • Australia

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Cardiovascular (CVS)

Disease

  • Hypertrophic cardiomyopathy

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A